A significant breakthrough in cancer investigation is emerging with the use of VHH fragments to re-engage damaged p53. This essential malignant inhibitor protein is frequently inactivated in various types of cancer, https://www.zenhealths.com/p53-reactivation-nanobody-cancer-research